Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

RecruitingOBSERVATIONAL
Enrollment

510

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

October 30, 2026

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Diagnostic test for prostate cancer

All recruited patients will undergo investigations including urine for spermine, blood for miRNA, TRUS, and MRI prostate. Patients with high suspicion of Clinically significant prostate cancer in any one step (urine, blood, ultrasound, OR MRI) will be offered an image-guided prostate biopsy.

Trial Locations (1)

Unknown

RECRUITING

Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER